Study of LJPC-401 Treatment for Hereditary Hemochromatosis Launches into Phase II
Hereditary hemochromatosis is a genetic form of a condition in which the body builds up too much iron. To read more about hemochromatosis, click here. La Jolla Pharmaceutical Company has…